AGL 37.55 Increased By ▲ 0.05 (0.13%)
AIRLINK 218.49 Decreased By ▼ -4.40 (-1.97%)
BOP 10.68 Decreased By ▼ -0.14 (-1.29%)
CNERGY 7.32 Decreased By ▼ -0.24 (-3.17%)
DCL 9.10 Decreased By ▼ -0.32 (-3.4%)
DFML 40.35 Decreased By ▼ -0.61 (-1.49%)
DGKC 102.20 Decreased By ▼ -4.56 (-4.27%)
FCCL 34.40 Decreased By ▼ -2.67 (-7.2%)
FFL 19.50 Increased By ▲ 0.26 (1.35%)
HASCOL 12.82 Decreased By ▼ -0.36 (-2.73%)
HUBC 130.69 Decreased By ▼ -1.95 (-1.47%)
HUMNL 14.42 Decreased By ▼ -0.31 (-2.1%)
KEL 5.27 Decreased By ▼ -0.13 (-2.41%)
KOSM 7.20 Decreased By ▼ -0.28 (-3.74%)
MLCF 45.45 Decreased By ▼ -2.73 (-5.67%)
NBP 65.79 Decreased By ▼ -0.50 (-0.75%)
OGDC 220.12 Decreased By ▼ -3.14 (-1.41%)
PAEL 44.25 Increased By ▲ 0.75 (1.72%)
PIBTL 9.08 Increased By ▲ 0.01 (0.11%)
PPL 192.28 Decreased By ▼ -5.96 (-3.01%)
PRL 41.60 Decreased By ▼ -0.64 (-1.52%)
PTC 26.69 Decreased By ▼ -0.70 (-2.56%)
SEARL 107.29 Decreased By ▼ -2.79 (-2.53%)
TELE 10.32 Decreased By ▼ -0.20 (-1.9%)
TOMCL 35.86 Decreased By ▼ -0.76 (-2.08%)
TPLP 14.48 Decreased By ▼ -0.47 (-3.14%)
TREET 25.86 Decreased By ▼ -0.67 (-2.53%)
TRG 67.34 Decreased By ▼ -1.51 (-2.19%)
UNITY 33.50 Decreased By ▼ -0.69 (-2.02%)
WTL 1.75 Decreased By ▼ -0.04 (-2.23%)
BR100 12,291 Decreased By -72.5 (-0.59%)
BR30 37,354 Decreased By -863.8 (-2.26%)
KSE100 116,637 Decreased By -482.9 (-0.41%)
KSE30 36,770 Decreased By -166.8 (-0.45%)
Markets

European stocks rise past two-week highs on earnings optimism

  • STOXX 600 on course for weekly gains
  • Chip stocks boosted by TSMC results
  • Publicis up on outlook hike
Published October 14, 2021

European stocks rose on Thursday, hitting the highest in more than two weeks as investors bet a steady economic recovery from the pandemic-induced slump will support corporate earnings despite signs of elevated inflation.

Mining shares jumped 3.3%, their biggest daily gain in three months, technology stocks rallied again and the pan-European STOXX 600 index rose 1.2%.

European chipmakers, including ASML, Infineon and BE Semiconductor, were among the top gainers in the tech sector after Taiwan chip giant TSMC posted a 13.8% jump in third-quarter profit due to booming demand for semiconductors.

China's factory gate inflation rose in September to a record high on soaring commodity prices. Many still hope inflation will be transitory, but supply chain disruptions, a global energy crisis and labour shortages have fuelled concerns that central banks could raise interest rates sooner, accelerating plans for a gradual exit from the pandemic-era stimulus.

"Equity markets appear to have shaken off their caution of recent weeks," said Chris Beauchamp, chief market analyst at IG. Upbeat results from Wall Street banks, big European names such as LVMH and SAP, as well as TSMC reinforced the view of a global economy still moving in the right direction, albeit at a slower place, he said.

Earnings boost stocks as markets brace for US inflation data

"Having dropped back in an orderly fashion into earnings season, it seems stock markets have now reached a level at which investors are once again happy about buying the dip..."

Optimism around the earnings has seen the STOXX 600 narrow the gap to its all-time highs to 2%.

Analysts expect third-quarter profit for STOXX 600 companies to climb 46.7% from a year ago, according to Refinitiv IBES data, with energy companies enjoying the biggest revisions.

Among individual stocks, French advertising group Publicis gained 2.7% after it raised its outlook for 2021 as a global shift towards digital media and e-commence helped third-quarter organic growth exceed market expectations. British rival WPP rose 0.5%.

Danish food ingredients maker Chr Hansen dropped 6.7% after fourth-quarter profit cam in below estimates.

SAP gained 2.9%, the biggest boost to the tech sector, after the German software firm's shares jumped nearly 4% in the previous session following a strong quarterly report.

The biggest drag on the STOXX 600 was AstraZeneca, down 0.5%. Europe's drug regulator said it had started a real-time review of the drugmaker's antibody-based COVID-19 therapy.

Comments

Comments are closed.